The potential regulatory mechanisms of MIR-196a in huntington's disease through bioinformatic analyses

Mu Hui Fu, Chia Ling Li, Hsiu Lien Lin, Shaw Jeng Tsai, Yen Yu Lai, Yu Fan Chang, Pei Hsun Cheng, Chuan Mu Chen, Shang Hsun Yang

研究成果: Article

12 引文 (Scopus)

摘要

High throughput screening is a powerful tool to identify the potential candidate molecules involved during disease progression. However, analysis of complicated data is one of the most challenging steps on the way to obtaining useful results from this approach. Previously, we showed that a specific miRNA, miR-196a, could ameliorate the pathological phenotypes of Huntington's disease (HD) in different models, and performed high throughput screening by using the striatum of transgenic mice. In this study, we further tried to identify the potential regulatory mechanisms using different bioinformatic tools, including Database for Annotation, Visualization and Integrated Discovery (DAVID), Molecular Signatures Database (MSigDB), TargetScan and MetaCore. The results showed that miR-196a dominantly altered "ABC transporters", "RIG-I-like receptor signaling pathway", immune system", "adaptive immune system","tissue remodeling and wound repair" and "cytoskeleton remodeling". In addition, miR-196a also changed the expression of several well-defined pathways of HD, such as apoptosis and cell adhesion. Since these analyses showed the regulatory pathways are highly related to the modification of the cytoskeleton, we further confirmed that miR-196a could enhance the neurite outgrowth in neuroblastoma cells, suggesting miR-196a might provide beneficial functions through the alteration of cytoskeleton structures. Since impairment of the cytoskeleton has been reported in several neuronal diseases, this study will provide not only the potential working mechanisms of miR-196a but also insights for therapeutic strategies for use with different neuronal diseases.

原文English
文章編號A1247
期刊PloS one
10
發行號9
DOIs
出版狀態Published - 2015 九月 16

指紋

Huntington Disease
Bioinformatics
cytoskeleton
Computational Biology
Cytoskeleton
bioinformatics
Immune system
Immune System
Chemical Databases
screening
Screening
ABC transporters
neurites
ATP-Binding Cassette Transporters
Throughput
disease models
Therapeutic Uses
MicroRNAs
Neuroblastoma
microRNA

All Science Journal Classification (ASJC) codes

  • Biochemistry, Genetics and Molecular Biology(all)
  • Agricultural and Biological Sciences(all)

引用此文

Fu, Mu Hui ; Li, Chia Ling ; Lin, Hsiu Lien ; Tsai, Shaw Jeng ; Lai, Yen Yu ; Chang, Yu Fan ; Cheng, Pei Hsun ; Chen, Chuan Mu ; Yang, Shang Hsun. / The potential regulatory mechanisms of MIR-196a in huntington's disease through bioinformatic analyses. 於: PloS one. 2015 ; 卷 10, 編號 9.
@article{ecc2c6e6e77e46858ea08747c66f4ed7,
title = "The potential regulatory mechanisms of MIR-196a in huntington's disease through bioinformatic analyses",
abstract = "High throughput screening is a powerful tool to identify the potential candidate molecules involved during disease progression. However, analysis of complicated data is one of the most challenging steps on the way to obtaining useful results from this approach. Previously, we showed that a specific miRNA, miR-196a, could ameliorate the pathological phenotypes of Huntington's disease (HD) in different models, and performed high throughput screening by using the striatum of transgenic mice. In this study, we further tried to identify the potential regulatory mechanisms using different bioinformatic tools, including Database for Annotation, Visualization and Integrated Discovery (DAVID), Molecular Signatures Database (MSigDB), TargetScan and MetaCore. The results showed that miR-196a dominantly altered {"}ABC transporters{"}, {"}RIG-I-like receptor signaling pathway{"}, immune system{"}, {"}adaptive immune system{"},{"}tissue remodeling and wound repair{"} and {"}cytoskeleton remodeling{"}. In addition, miR-196a also changed the expression of several well-defined pathways of HD, such as apoptosis and cell adhesion. Since these analyses showed the regulatory pathways are highly related to the modification of the cytoskeleton, we further confirmed that miR-196a could enhance the neurite outgrowth in neuroblastoma cells, suggesting miR-196a might provide beneficial functions through the alteration of cytoskeleton structures. Since impairment of the cytoskeleton has been reported in several neuronal diseases, this study will provide not only the potential working mechanisms of miR-196a but also insights for therapeutic strategies for use with different neuronal diseases.",
author = "Fu, {Mu Hui} and Li, {Chia Ling} and Lin, {Hsiu Lien} and Tsai, {Shaw Jeng} and Lai, {Yen Yu} and Chang, {Yu Fan} and Cheng, {Pei Hsun} and Chen, {Chuan Mu} and Yang, {Shang Hsun}",
year = "2015",
month = "9",
day = "16",
doi = "10.1371/journal.pone.0137637",
language = "English",
volume = "10",
journal = "PLoS One",
issn = "1932-6203",
publisher = "Public Library of Science",
number = "9",

}

The potential regulatory mechanisms of MIR-196a in huntington's disease through bioinformatic analyses. / Fu, Mu Hui; Li, Chia Ling; Lin, Hsiu Lien; Tsai, Shaw Jeng; Lai, Yen Yu; Chang, Yu Fan; Cheng, Pei Hsun; Chen, Chuan Mu; Yang, Shang Hsun.

於: PloS one, 卷 10, 編號 9, A1247, 16.09.2015.

研究成果: Article

TY - JOUR

T1 - The potential regulatory mechanisms of MIR-196a in huntington's disease through bioinformatic analyses

AU - Fu, Mu Hui

AU - Li, Chia Ling

AU - Lin, Hsiu Lien

AU - Tsai, Shaw Jeng

AU - Lai, Yen Yu

AU - Chang, Yu Fan

AU - Cheng, Pei Hsun

AU - Chen, Chuan Mu

AU - Yang, Shang Hsun

PY - 2015/9/16

Y1 - 2015/9/16

N2 - High throughput screening is a powerful tool to identify the potential candidate molecules involved during disease progression. However, analysis of complicated data is one of the most challenging steps on the way to obtaining useful results from this approach. Previously, we showed that a specific miRNA, miR-196a, could ameliorate the pathological phenotypes of Huntington's disease (HD) in different models, and performed high throughput screening by using the striatum of transgenic mice. In this study, we further tried to identify the potential regulatory mechanisms using different bioinformatic tools, including Database for Annotation, Visualization and Integrated Discovery (DAVID), Molecular Signatures Database (MSigDB), TargetScan and MetaCore. The results showed that miR-196a dominantly altered "ABC transporters", "RIG-I-like receptor signaling pathway", immune system", "adaptive immune system","tissue remodeling and wound repair" and "cytoskeleton remodeling". In addition, miR-196a also changed the expression of several well-defined pathways of HD, such as apoptosis and cell adhesion. Since these analyses showed the regulatory pathways are highly related to the modification of the cytoskeleton, we further confirmed that miR-196a could enhance the neurite outgrowth in neuroblastoma cells, suggesting miR-196a might provide beneficial functions through the alteration of cytoskeleton structures. Since impairment of the cytoskeleton has been reported in several neuronal diseases, this study will provide not only the potential working mechanisms of miR-196a but also insights for therapeutic strategies for use with different neuronal diseases.

AB - High throughput screening is a powerful tool to identify the potential candidate molecules involved during disease progression. However, analysis of complicated data is one of the most challenging steps on the way to obtaining useful results from this approach. Previously, we showed that a specific miRNA, miR-196a, could ameliorate the pathological phenotypes of Huntington's disease (HD) in different models, and performed high throughput screening by using the striatum of transgenic mice. In this study, we further tried to identify the potential regulatory mechanisms using different bioinformatic tools, including Database for Annotation, Visualization and Integrated Discovery (DAVID), Molecular Signatures Database (MSigDB), TargetScan and MetaCore. The results showed that miR-196a dominantly altered "ABC transporters", "RIG-I-like receptor signaling pathway", immune system", "adaptive immune system","tissue remodeling and wound repair" and "cytoskeleton remodeling". In addition, miR-196a also changed the expression of several well-defined pathways of HD, such as apoptosis and cell adhesion. Since these analyses showed the regulatory pathways are highly related to the modification of the cytoskeleton, we further confirmed that miR-196a could enhance the neurite outgrowth in neuroblastoma cells, suggesting miR-196a might provide beneficial functions through the alteration of cytoskeleton structures. Since impairment of the cytoskeleton has been reported in several neuronal diseases, this study will provide not only the potential working mechanisms of miR-196a but also insights for therapeutic strategies for use with different neuronal diseases.

UR - http://www.scopus.com/inward/record.url?scp=84945924231&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84945924231&partnerID=8YFLogxK

U2 - 10.1371/journal.pone.0137637

DO - 10.1371/journal.pone.0137637

M3 - Article

C2 - 26376480

AN - SCOPUS:84945924231

VL - 10

JO - PLoS One

JF - PLoS One

SN - 1932-6203

IS - 9

M1 - A1247

ER -